Volume | 1,115,931 |
|
|||||
News | - | ||||||
Day High | 79.00 | Low High |
|||||
Day Low | 78.30 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Alcon Inc | ALC | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
78.32 | 78.30 | 79.00 | 78.77 | 78.84 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
14,740 | 1,115,931 | $ 78.79 | $ 87,920,997 | - | 69.44 - 88.2312 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:00:00 | 52,473 | $ 78.77 | USD |
Alcon Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
27.06B | 499.70M | - | 9.46B | 974M | 1.95 | 27.78 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Alcon News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ALC Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 79.42 | 81.43 | 78.00 | 79.80 | 859,874 | -0.65 | -0.82% |
1 Month | 83.32 | 84.96 | 78.00 | 81.41 | 880,908 | -4.55 | -5.46% |
3 Months | 75.35 | 88.2312 | 74.30 | 82.22 | 919,900 | 3.42 | 4.54% |
6 Months | 70.51 | 88.2312 | 69.44 | 78.27 | 882,114 | 8.26 | 11.71% |
1 Year | 72.04 | 88.2312 | 69.44 | 78.77 | 819,532 | 6.73 | 9.34% |
3 Years | 75.98 | 88.78 | 55.21 | 74.26 | 860,172 | 2.79 | 3.67% |
5 Years | 57.69 | 88.78 | 39.37 | 67.40 | 975,425 | 21.08 | 36.54% |
Alcon Description
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun-off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan. |